TwinBeech Capital’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
Other funds holding AMLX
SVCM
TwinBeech Capital's AMLX Position: Q3 2026 in Review
TwinBeech Capital opened a new position in Amylyx Pharmaceuticals (AMLX) in Q3 2026: 42,428 shares worth $1.23M. The stake represents 0.29% of the portfolio and ranks #107 among its holdings. This is a return to the name: TwinBeech Capital previously reported a position in AMLX as recently as Q1 2024.
TwinBeech Capital first reported a position in AMLX in Q1 2023 and has held it in 6 quarters since. The position peaked at $3.87M in Q1 2023. 230 funds tracked by Wall St. Rank hold AMLX as of Q3 2026.
- TwinBeech Capital held 42,428 shares of Amylyx Pharmaceuticals worth $1.23M as of Q3 2026.
- Amylyx Pharmaceuticals was a new TwinBeech Capital position in Q3 2026.
- Amylyx Pharmaceuticals made up 0.29% of TwinBeech Capital's portfolio in Q3 2026, its #107 holding.
- TwinBeech Capital first reported a position in Amylyx Pharmaceuticals in Q1 2023 and has held it in 6 quarters since.
- TwinBeech Capital's Amylyx Pharmaceuticals position peaked at $3.87M in Q1 2023.
- 230 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q3 2026.
Based on TwinBeech Capital's 13F filing for Q3 2026, filed 16 Nov 2026.